Perrigo (PRGO) Change in Account Payables (2013 - 2026)
Perrigo (PRGO) reported Change in Account Payables of -$35.9 million for Q1 2026, down 598.61% year-over-year from $7.2 million in Q1 2025, and down 915.91% quarter-over-quarter from $4.4 million in Q4 2025.
Perrigo (PRGO) Change in Account Payables (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has 14 years of Change in Account Payables data on file, last reported at -$35.9 million in Q1 2026.
- Change in Account Payables for Q1 2026 came in at -$35.9 million, down 598.61% year-over-year; the trailing twelve-month figure through Mar 2026 was -$71.8 million (down 191.93% YoY), and the FY2025 annual result was -$28.7 million, down 152.95% from the prior year.
- Change in Account Payables retreated to -$35.9 million in Q1 2026 per PRGO's latest filing, from $4.4 million in the prior quarter.
- Over five years, Change in Account Payables peaked at $72.6 million in Q2 2022 and troughed at -$39.0 million in Q3 2023.
- A 5-year average of $1.4 million and a median of -$13.2 million in 2025 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2022 and 2026: Change in Account Payables surged 2068.0% in 2022, then sank 598.61% in 2026.
- A 5-year view of Change in Account Payables shows it stood at $54.2 million in 2022, then sank by 50.18% to $27.0 million in 2023, then jumped by 118.89% to $59.1 million in 2024, then sank by 92.55% to $4.4 million in 2025, then tumbled by 915.91% to -$35.9 million in 2026.
- Business Quant data shows PRGO's Change in Account Payables at -$35.9 million in Q1 2026, $4.4 million in Q4 2025, and -$13.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 62.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | - |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | - |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 190,000.00 |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 562,000.00 |
| 10 | Perrigo | 1.52 Bn | 1.17 Bn | 325.50 Mn | -35.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -35.90 Mn |
| Mar 28, 2026 | -35.90 Mn |
| Dec 31, 2025 | 4.40 Mn |
| Dec 31, 2025 | 4.40 Mn |
| Sep 27, 2025 | -13.20 Mn |
| Sep 27, 2025 | -13.20 Mn |
| Jun 28, 2025 | -27.10 Mn |
| Jun 28, 2025 | -27.10 Mn |
| Mar 29, 2025 | 7.20 Mn |
| Mar 29, 2025 | 7.20 Mn |
| Dec 31, 2024 | 59.10 Mn |
| Dec 31, 2024 | 59.10 Mn |
| Sep 28, 2024 | -18.80 Mn |
| Sep 28, 2024 | -18.80 Mn |
| Jun 29, 2024 | 30.60 Mn |
| Jun 29, 2024 | 30.60 Mn |
| Mar 30, 2024 | -16.70 Mn |
| Mar 30, 2024 | -16.70 Mn |
| Dec 31, 2023 | 27.00 Mn |
| Dec 31, 2023 | 27.00 Mn |